Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

3.200 -0.080 (-2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,487
Open 3.360
Bid (Size) 3.000 (10)
Ask (Size) 3.500 (16)
Prev. Close 3.280
Today's Range 3.180 - 3.360
52wk Range 2.100 - 4.380
Shares Outstanding 52,388,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024
ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
-21.57%
-21.57%
1 Month
-9.86%
-9.86%
3 Month
-6.43%
-6.43%
6 Month
-3.03%
-3.03%
1 Year
+30.08%
+30.08%

More News

Read More
The Latest Analyst Ratings for Alimera Sciences
Via Benzinga
Preview: Alimera Sciences's Earnings
Via Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
Via Newsfile
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Via Benzinga
Expert Ratings for Alimera Sciences
Via Benzinga
4 Analysts Have This to Say About Alimera Sciences
Via Benzinga
Earnings Outlook For Alimera Sciences
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
A Preview Of Alimera Sciences's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
Via InvestorPlace
US Stocks Mixed; Jobless Claims Drop More than Projected
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.